Strong inhibition of HIF-1α by EZN-2968 (Fig 3I) recapitulated more efficiently what was previously observed by chronic HIF-1α silencing: blockade of cell migration and CFU-L efficacy upon re-plating (Fig 3J and K), as well as delayed leukemia progression (Fig 3L). The gene discussed is HIF1A; the disease is leukemia.